Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease progression is associated with differential neutrophil maturation in Mycobacterium tuberculosis-infected macaques.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Genetically diverse CC and DO mouse models enable comprehensive assessments of novel tuberculosis vaccines.

NPJ vaccines·2026
Same author

CD1a-Mediated Presentation of Canonical Microbial Peptides to T Cells.

bioRxiv : the preprint server for biology·2026
Same author

Smooth-to-rough morphotype alterations in <i>Mycobacterium abscessus</i> and their putative impact on phage resistance.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

An ESAT-6-convergent prime-boost vaccination combining recombinant BCG expressing Mycobacterium marinum ESX-1 and ESAT-6/GLA-SE improves TB protection.

NPJ vaccines·2026
Same author

Improved immune responses and tuberculosis protection by aerosol vaccination with recombinant BCG expressing ESX-1 from Mycobacterium marinum.

PLoS pathogens·2026
Same journal

Host-derived proteomic biomarkers for discriminating the tuberculosis disease spectrum in a Brazilian cohort.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Association between gut microbiota and white matter microstructural damage in tuberculous meningitis patients.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Context-dependent transcriptional and epigenetic reprogramming shapes neutrophil antimicrobial and immunoregulatory functions in tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Discovery and identification of a handwritten laboratory notebook by Albert Calmette and Camille Guérin describing experimental studies and development of the BCG vaccine for tuberculosis at the Institut Pasteur.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Delineating the potential of bioenergetics in drug discovery against Mycobacteriumabscessus.

Tuberculosis (Edinburgh, Scotland)·2026
Same journal

Association of vitamin D status with the immune response in active pulmonary tuberculosis patients with chronic pulmonary aspergillosis.

Tuberculosis (Edinburgh, Scotland)·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

TBCAP; tuberculosis annotation project

Patrick J Brennan, Roland Brosch, Bruce Birren

    Tuberculosis (Edinburgh, Scotland)
    |January 22, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
    07:35

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

    Published on: April 25, 2014

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021

    Related Experiment Videos

    Last Updated: May 15, 2026

    A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
    10:41

    A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

    Published on: April 30, 2020

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
    07:35

    Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

    Published on: April 25, 2014

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
    09:34

    An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

    Published on: August 16, 2021